• Eat Well Investment Group Inc. is a plant-based foods focused investment company dedicated to helping consumers pursue healthier food options while sustaining global food security
• Eat Well’s investments include subsidiaries Belle Pulses, Sapientia and Amara Organic Foods and establish a portfolio of plant-based food production companies targeting protein alternative and natural baby food markets
• Distribution agreements with companies such as Walmart, Whole Foods, Sprouts Farmer’s Market, Loblaws and HEB Grocery Company (H-E-B) are making it possible for Eat Well’s investee companies to rapidly increase their consumer reach
• The company recently announced developments in a special warrant indenture that will trade on the Canadian Securities Exchange through December 2024 as part of its efforts to welcome new investment

When Sodexo Campus, the college and university arm of international foodservice giant Sodexo, announced this month that it will expand its plant-based menu items to 42 percent of the total meals it offers at hundreds of universities across the United States, it heralded the growing importance consumers place on earth-friendly, nutritious plant-based foods, as noted by industry e-magazine Veg News (https://ibn.fm/9zLSS). “When you see there are more than 20,000 known edible plants on our planet, and yet our food comes primarily from a dozen of them, there is definitely [an] opportunity to change and discover new ways of eating,” Sodexo Food Platform Senior Vice President John Wright stated a few years ago, as reported by VegNews. “Today, we are helping consumers as they look for ways to adopt more sustainable diets.” The article also reported that a recent survey conducted by Innova Health & Nutrition found that 23 percent of the participants who are between 18 and 25 years old maintain a vegetarian or a vegan diet, and that nearly one-third of youth boosted their consumption of plant-based proteins in 2021 alone. Eat Well Investment Group (CSE: EWG) (OTC: EWGFF) is a vertically integrated plant-based foods investment company that has been rapidly building its portfolio of production and distribution brands during the past year to market to the growing consumer interest in plant-based foods. Bloomberg Intelligence analysts reported expectations that the plant-based market will see explosive growth in coming years, forecasting plant-based foods will increase their representation in the global protein market to 7.7 percent by 2030 with an exponential increase in valuation to more than $162 billion (https://ibn.fm/ZSK2a). Eat Well’s three major investments — ingredients processor Belle Pulses, food creator Sapientia and baby food brand Amara Organic Foods — sold over 26,000 tons of pure plant-based protein to over 35 countries worldwide during the first year of the pandemic and continue to exemplify Eat Well’s drive to help consumers not only eat more nutritiously, but also participate in global efforts to minimize industrial impacts on the world’s climate. During the course of last year, Eat Well gained nearly $60 million (Canadian) in revenue while showing its subsidiaries’ acumen for dealing with supply chain troubles and market issues arising from the worldwide COVID pandemic. The company’s products are gaining increased distribution through companies such as Walmart, Whole Foods, Sprouts Farmer’s Market, Loblaws and HEB Grocery Company (H-E-B). “It has always been our investment thesis that the globe will shift to more sustainable and environmentally friendly proteins,” CEO and Director Marc Aneed stated earlier this month in a discussion of the company’s efforts to expand global pulse production amid the market disruption caused by the war in Ukraine (https://ibn.fm/0XzFe). “The next 24 months will be crucial for international food security as one of the world’s largest producers of fertilizer, agricultural crops and pulses is effectively closed off from the rest of the world.” For more information, visit the company’s website at www.EatWellGroup.com. NOTE TO INVESTORS: The latest news and updates relating to EWGFF are available in the company’s newsroom at https://ibn.fm/EWGFF

The Catalyst Summit 2022 will be held from Friday, May 20th to Sunday, May 22nd, 2022, at Queen’s University, Kingston, Ontario. The event can also be attended online. In its third annual edition, Catalyst Summit 2022 is the premier Canadian conference dedicated to Psychedelic Medicine, and its growing role in the medical industry, society, and commerce. Political officers, city administrators, budding entrepreneurs, psychedelic researchers, medical & science specialists, legal experts, and health professionals are warmly invited to attend. The conference agenda will include keynote sessions, networking events, panel discussions, presentations, and in-depth discussions with over 80 renowned speakers, including seasoned researchers from world-class universities, industry leaders, senators, and medical experts in a variety of areas related to psychedelics. The conference will explore a wide array of topics related to Psychedelic Medicine, drawing upon the latest science-backed data and evidence from clinical trials from around the world. Key themes include Standards, Ethics, and Best Practices; Legal and Regulatory Frameworks; The Business of Psychedelics; Pre-Screening and After-Medicine Integration; Safe, Legal Medicine Sourcing for Therapeutic Use; and Therapeutic Models and Protocols. Distinguished speakers include Senator Larry Campbell; Kingston Deputy Mayor Gary Oosterhof; author of seven books and Invention Ambassador for the American Association for the Advancement of Science (“AAAS”), Paul Stamets; Dean of Health Sciences at Queen’s University and the CEO of the Southeastern Ontario Academic Medical Association (“SEAMO”), Jane Philpott, and clinical assistant professor of psychiatry at NYU, Anthony P. Bossis, Ph.D., among several others. Attendees will also have the opportunity to network and foster relationships with industry peers at the After Party sponsored by the Psychedelic Association of Canada between 9 pm and 11 pm EST on Friday, May 20th. The 3rd Annual Catalyst Summit is organized by Catalyst Presents Foundation, a premier organization well-recognized in the industry for events that enable networking opportunities, knowledge sharing, policy discussions, and lead generation with the objective of guiding Canada’s Psychedelic Journey. The event will include an ‘In Conversation’ session with Health Canada representatives, moderated by David Clements, and a series of presentations with live Q&A sessions. Dedicated sessions will examine psychedelic therapy, the role of the media vis-à-vis psychedelics, palliative care, ethics and consent, care for trauma, supply chain efficiencies, and business regulation. The conference’s first session will be An Evening with Paul Stamets and special guests Dr. Jane Philpott, Larry Campbell, Kingston Deputy Mayor Gary Oosterhof, David Harder, and Natalie Harder from 7 – 9 pm on Friday, May 20th. To learn more about the event, please visit https://catalystpresents.ca/

Investors, entrepreneurs, psychedelic researchers, environmentalists, tech experts, medical & science specialists, and health professionals, are invited to attend the Microdose Psychedelic Capital Conference on May 26, 2022 as an online event. Microdose is a premier global psychedelic network group. It is focused on growing the psychedelic industry and driving it to the forefront of modern medicine by sharing valuable content, organising networking events, analysing reports, and offering the latest news and strategies. The virtual conference is a robust psychedelic platform that offers exposure to psychedelic dedicated ventures that are trying to carve a niche for themselves. Businesses can showcase their products and skills to avail the phenomenal investor opportunities available at this forum. Enthusiasts and capitalists looking for investment opportunities can discover the untapped potential to develop, launch and market novel psychedelic supplies in the market. The agenda of the conference will include discussions, keynotes, and insights from world-class speakers, top companies, latest IPOs about the potential and scope of investments in the psychedelic sector. The Microdose conference will explore pre-IPO opportunities in the psychedelic investment sector. Thought leaders, influencers, and entrepreneurs attending the conference will share insights and discuss the latest innovations in drug development, and the financial, scientific, and industrial news in the psychedelic world. Learn about the laws and regulations and current business trends driving the psychedelic industry. A part of the bi-monthly investor series, this virtual Microdose Conference explores the new technologies driving the industry, the scope of psychedelic investments and the prospects.  It offers a forum to connect businesses to the top capitalists and investors of the psychedelic spectrum. These online sessions offer tremendous networking scope where businesses build strong ties and associations. Many global leaders of the psychedelic spectrum will reside as speakers to share their views, announce new products and impart insights into the future trends of this industry. The introduction of the Microdose event will be given by:

• Patrick Moher, the President of Microdose Psychedelics Insights, is a dynamic entrepreneur working on creating innovative business opportunities in psychedelic industries, across the social and economic spectrum for upcoming industries. 
• Richard Skaife, Chair, Microdose, The Conscious Fund, a veteran in mental health, technology and investment, accredited with the multi-million downloaded Digipill app.

Microdose Psychedelic Capital Conference recordings are accessible to ticket holders for a lifetime. Every company’s pitch deck is also available for viewing and access by ticket holders.  To learn more, please visit https://ibn.fm/Ii1VO.

• DraftKings sees no inflationary impact on player demand in first quarter report
• While major B2C online gaming companies struggle with exorbitant costs, Golden Matrix’s B2C model has resulted in 14 consecutive profitable quarters
• Golden Matrix acquired 80% of B2C prize competition company RKings Competitions Ltd, an immediately accretive move that facilitates expansion into new markets

While it would seem logical that periods of rising inflation would cause a slowdown within the gambling industry as consumers tighten their purse strings, history says otherwise. Growth remains mostly unabated because the benefits of wider legalization have outweighed economic impacts, particularly in recent years as more U.S. states join the legal and online gambling renaissance. That said, competition has increased, meaning operators have to be more mindful than ever before about controlling user acquisitions costs (“UAC”), which plays right into the hands of Golden Matrix Group (NASDAQ: GMGI), which has its roots in B2B (business-to-business) products as it matriculates into B2C (business-to-consumer) with a unique model. DraftKings (NASDAQ: DKNG) is a prime representative of the B2C market today. In their recent report on the first quarter of 2022, the company conveyed that they weren’t seeing any impact from inflationary pressures on customer demand as it grew Q1 revenue 34% from the year prior quarter to $417 million. Operating expenses surge 46% y-o-y to $933 million, contributing to a net loss of $468 million for the quarter. DraftKings pegged its average revenue per monthly unique player (“MUP”) at $67, up 11% from Q1 2021. Point being, it’s an expensive dogfight in the U.S. to win customers in states where gambling is legal and to expand into states where online betting is launching. The U.S. is a convenient example, but the trend is similar throughout the world. Golden Matrix is not the company featured during halftime commercials, but they are the company that can make it possible for online operators to better afford paying for them. Not having a huge marketing burn is a big part of the reason that GMGI has reported 14 straight profitable quarters. The Las Vegas-based company is primarily active in the Asia Pacific region where it is a leading provider of turnkey and white label gaming platforms, Esports technology and gaming content. The company is highly differentiated from peers as it pioneers highly modular, configurable, and scalable gaming platforms (both mobile and desktop and agnostic to operating system) designed specifically to efficiently promote user acquisition, engagement, retention, and monetization. Leading gaming content providers such as Asia Gaming, GameArt, Microgaming, Playtech, and many more provide their state of the art and world dominant casino games to Golden Matrix’s GM-X System, which include a swath of products spanning slots, live games, sports, and table games. The GM-X and GMX-Ag platforms are the industries benchmark, providing access to over 10,000 games across more than 25 providers. In April, Golden Matrix took its new B2B aggregate gaming system, GMX-Ag, live with eight established online casino operators in six countries. While strategic and timely to expand its B2B offerings in APAC, Golden Matrix CEO Brian Goodman sees the new GMX-Ag suite as opening new market opportunities outside of its traditional markets. While it executes on expansion via organic growth, Golden Matrix is also looking to acquisitions to accelerate expansion. In December, the company completed buying 80% of B2C prize competition company RKings Competitions Ltd, with provisions to buy the remaining 20% in the future. RKings represents GMGI’s foray into the B2C competition space, a market that has been thriving for decades as a means for brands to get in front of consumers. RKings has a presence throughout the U.K. and Europe and Goodman expects the popularity to resonate in new markets. First up is Mexico where Golden Matrix now has a gaming permit pending. Other jurisdictions are expected to follow. While most online gaming companies continue to struggle to contain costs, much less reach profitability, Golden Matrix continues to shine. Combining revenue streams post-acquisition helped bolster GMGI’s overall financial performance during the first fiscal quarter ended January 31, 2022. Revenue surged 355% y-o-y to $8.88 million. “Due to the platform’s scalability, coupled with low player acquisition and marketing costs, we expect RKings’ contributions to revenues and profits to grow significantly in the months and years ahead,” said Goodman. For more information, visit the company’s website at www.GoldenMatrix.com. NOTE TO INVESTORS: The latest news and updates relating to GMGI are available in the company’s newsroom at https://ibn.fm/GMGI

• Luis Merchan, Flora Growth’s CEO, will serve as the new Chairman of the Board
• Tim Leslie, the Chairman of the company’s Advisory Board, will serve on its Board and audit committee
• Flora Growth’s management is confident that these changes will position it as a U.S-based issuer while increasing its access to U.S-based investment

Since the beginning of 2022, Flora Growth (NASDAQ: FLGC) has been making strategic moves that strengthen its human resources and reinforce its executive team. The company kicked off the year with the appointment of Tim Leslie as the Chairman of its newly formed Advisory Board (https://ibn.fm/dL9mm). Later, Flora Growth appointed Derek Pedro, a world-renowned cannabis genetics and cultivation expert, as an advisor to its Cosechemos cultivation facility (https://ibn.fm/KVBfP). Two more appointments were made after that, starting with Joël Reyes as Senior Vice President (“SVP”) of Global Operations and Jessie Casner as the company’s new Chief Marketing Officer (“CMO”) (https://ibn.fm/QonRU). In a move that sought to take the company even further, on March 17, 2022, Flora Growth announced changes to its Board of Directors. Tim Leslie, the Chairman of the Advisory Board, was added to the Board of Directors (“the Board”) and audit committee. In addition, Luis Merchan, Flora Growth’s Chief Executive Officer (“CEO”), took over from Bernie Wilson as the Chairman of the Board. Mr. Wilson will remain in an advisory capacity for the remainder of the year and will be integral in providing strategic guidance on capital markets and international expansion (https://ibn.fm/h8rum). “I am honored that our Board has entrusted me with this role, and I believe it is a testament to what we have built together thus far,” noted Luis Merchan. “Our Board has been incredibly supportive to date while always ensuring business decisions are in the best interest of our shareholders- and I am looking forward to continuing to work closely with them in this role,” he added. Luis Merchan has been instrumental in expanding Flora Growth’s reach within the United States and abroad. He has moved the company from the development stage to a full-scale international distributor with operations in over 12 countries worldwide. In addition, under his leadership, Flora Growth has completed several mergers and acquisitions (“M&As”), all of which have set the company up for rapid growth. The company will continue to benefit from Mr. Leslie’s insights and guidance as it advances its rapid global expansion. He has vast experience in the industry, including two decades at Amazon, which will be instrumental for Flora Growth’s expansion going forward. Flora Growth is confident that its Board’s changes will further position it as a U.S-based issuer. It is also optimistic that the move will increase its access to U.S-based investment. For more information, visit the company’s website at www.FloraGrowth.com. NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://ibn.fm/FLGC

• Delic Holdings Corp. comprises several businesses—Delic Labs, Meet Delic, and Ketamine Wellness Centers and media properties Reality Sandwich and Delic Radio
• The psychedelic drugs market is expected to reach US $9,818.68 million by 2029 – primarily driven by an increase in acceptance for use in mental health
• The company’s goal is to expand its clinic offering to 60-70% of the American population driving no more than 45-minutes to reach a clinic

Delic Holdings (CSE: DELC) (OTCQB: DELCF), a leader in new medicines and treatments for a modern world, is committed to bringing the science-backed benefits of psychedelics to more people and reframing the conversations about them. The company owns and operates an assortment of related businesses, including two media platforms (Reality Sandwich and Delic Radio), a Health Canada-licensed entity focusing on the research and development of psilocybin vaporization technology (Delic Labs), a premier psychedelic wellness event (Meet Delic), and the largest network of ketamine clinics in the country (Ketamine Wellness Centers). Delic is backed by a team of industry and cannabis veterans who, alongside a diverse network, share a mission to provide education, research, high-quality products, and treatment options to the population. The company is uniquely positioned to capitalize on the psychedelic drugs market, an expanding sector whose growth is primarily driven by an increased acceptance of psychedelics use for mental health. According to Data Bridge Market Research, the psychedelic drugs market was valued at US $2,834.72 million in 2021. The market is expected to grow at a CAGR of 16.8%, resulting in a value of US $9,818.68 million by 2029 (https://ibn.fm/VRf9G). Delic Holdings company has received a Health Canada 56 Health Exemption, which allows Delic’s scientists to do research with numerous compounds outside of psychedelic mushrooms, including MDMA (ecstasy), LSD, DMT (Dimitri), mescaline, and 2C-B. Health Canada also authorized Delic Labs to acquire 60 grams of psilocybin mushrooms from Nectar Health Sciences Laboratory Division Inc. The lab has also applied for a Dealer’s License, which would allow it to commercialize its research into psilocybin and associated IP for medical and research purposes. In a January interview, Delic CEO and co-founder Matt Stang explained that there are 51.5 million Americans who have experienced a mental health condition, and the ongoing pandemic has only exacerbated the crisis. This increase in mental health issues has led to a stronger demand for alternatives to current treatments with lasting outcomes and fewer side effects (https://ibn.fm/ikrCw). “At Delic, we have built the most profitable model for scaling the best-in-class care directly to patients through the largest network of mental health clinics in the U.S.,” Stang added. “We see a strong outlook for Delic with the rollout of 15 additional clinics and an expansion into communities where access to these life-changing treatments is very limited. Delic is well-positioned for growth and profitability in 2022 and beyond.” The company currently operates 13 wellness clinics across nine states and intends to expand the clinic offering to multiple other locations. The company’s long-term vision for expansion is to have 60-70% of the American population within a 45-minute drive of a clinic. The company also anticipates FDA approval being a reality in the future for compounds like MDMA and psilocybin. Once the psychedelic drugs have received some form of FDA approval, “Delic will be the place you can go – you’ll have a clinic in your backyard that you go to for psychedelic medicine treatment, just like any other type of pharmaceutical,” Stang explained in an interview. He further noted that these clinics would offer psychedelic treatments on an in-person basis. Qualified professionals will sit with the patients, walk them through the process, offer them the efficacy they seek, and help them [as a result] change their minds and lives (https://ibn.fm/WfxU1). For more information, visit the company’s website at www.DelicCorp.com. NOTE TO INVESTORS: The latest news and updates relating to DELCF are available in the company’s newsroom at https://ibn.fm/DELCF

• SGMD enters into a definitive agreement designed to expand its cannabis delivery footprint
• Company inks deal to establish a minority stake in an expanding reservation-only restaurant brand that includes private event space offering cannabis consumption
• Sugarmade also partners with BHG to be first-choice cannabis provider

The cannabis space is known for its competition, but Sugarmade (OTC: SGMD), an emerging leader in the sector, has distinguished itself by its smart, creative decisions. Sugarmade has once again showed its expertise in savvy business strategy by announcing plans to establish a new hub for cannabis delivery and partnering with an expanding reservation-only restaurant brand with an adjacent private event space that offers cannabis consumption (https://ibn.fm/QCKh2). Last month Sugarmade entered into a definitive agreement designed to expand its cannabis delivery footprint. The agreement established SGMD’s majority ownership in a fully licensed new Hollywood cannabis delivery hub located on the world-famous Sunset Strip. Based on the agreement, the company will receive 100% of all profits from the new delivery hub until it has made back its capital investment; following that, Sugarmade will receive 51% of profits. The new cannabis retail distribution hub will offer delivery to the affluent neighborhoods of the West Hollywood Hills. “This investment lands us on the ground floor of a new concept for cannabis distribution in the world’s biggest cannabis marketplace,” said Sugarmade CEO Jimmy Chan. In addition to the cannabis delivery agreement, Sugarmade also inked a deal to establish a minority stake in an expanding reservation-only restaurant brand with a unique feature: the establishment includes an adjacent private event space that offers cannabis consumption. The restaurant is also located on Sunset Strip. In addition, the company partnered with Boulevard Hospitality Group, which is best known for operating Yamashiro, an iconic Hollywood Hills restaurant that is more than a century old. This collaboration calls for Sugarmade to be the first-choice provider of cannabis as BHG explores opportunities to open cannabis-only venues. “Through these agreements, we are simultaneously adding a new cannabis end market with future growth potential, doubling our delivery coverage in the LA metro area, and creating a new and more diversified revenue profile,” said Chan. “We believe all of these steps represent strong potential drivers for shareholder value.” Sugarmade is a product and branding marketing company investing in operations and technologies with disruptive potential. The company’s brand portfolio includes CarryOutsupplies.com, SugarRush, NUG Avenue and Lemon Glow. For more information, visit the company’s website at www.Sugarmade.com. NOTE TO INVESTORS: The latest news and updates relating to SGMD are available in the company’s newsroom at http://ibn.fm/SGMD

• The ‘Internet of Things’ market is expected to reach a value of between $5.5 trillion and $12.6 trillion by 2030, from $745 billion in 2019, driven by contributions from both businesses and consumers
• SPYR Inc., through its subsidiary Applied Magix Inc., is considering aligning its interests to tap into this anticipated rapid growth
• The company is considering developing software for non-branded smart products, adding smart LED lighting products to its portfolio of HomeKit-enabled smart products, and acquiring new product lines or intellectual property

Research released late last year by multinational consulting firm McKinsey posits that the Internet of Things (“IoT”) space will grow through 2030, unlocking a potential economic value of between $5.5 trillion and $12.6 trillion, up from recorded spending of $745 billion in 2019 (https://ibn.fm/Kh1EA). Central to this economic-value potential is the contribution of the customers of IoT products, who are expected to be drawn from both the business-to-business (“B2B”) and business-to-consumer (“B2C”) segments (https://ibn.fm/Z3dyV). “B2B applications are where the majority of IoT value can be created, with around 65% of the estimated IoT value potential by 2030. But the value of B2C applications is growing quickly, spurred by faster-than-expected adoption of IoT solutions within the home,” the McKinsey report reads. SPYR (OTCQB: SPYR), dba SPYR Technology, whose Applied Magix, Inc. subsidiary develops and resells Apple(R)-ecosystem-compatible products, is aware of this potential and is positioning itself to tap into the expected growth through a multipronged forward-looking expansion strategy. First, SPYR is considering developing software for non-branded smart products to augment the user experience (“UX”), expanding its portfolio of products without having to undertake new hardware development (https://ibn.fm/xsZx8). “In our research into viable products to manufacture or carry, we have come across a number of manufacturers in China with well-engineered, often excellent hardware, yet abysmally poor software. Since the software is the main point of interaction for customers, badly designed software inevitably results in a bad customer impression of the product,” commented Applied Magix CEO Dr. Harald Zink. “By selecting well-engineered products and re-engineering a better software to accompany them, we hope to gain the best of both worlds – low development costs (as we don’t have to develop new hardware) and additions to our product line in the form of both the software product, as well as reselling the hardware product with minimal overhead.” SPYR is also probing the addition of the MagixLux LED lighting line of HomeKit-enabled smart LED lighting products to its existing portfolio of HomeKit-enabled smart products (https://ibn.fm/QLQH0). “There are a number of good LED lightning products already on the market – many of which we recommend – but I felt that we can round out our product line by offering HomeKit compliant LED lighting bulbs and atmosphere-enhancing LED light strips to complement the various HomeKit sensors we are already offering,” noted Zink. Mordor Intelligence projects that the global smart lighting market, valued at $12.72 billion in 2020, will grow at a CAGR of about 20.26% between 2021 and 2026, nudging the value upwards to top out at $37.41 billion by the end of the forecast period. The firm’s analysts opine that the societal benefits of energy-efficient LED technology could prompt a prodigious number of consumers to adopt smart LED lighting (https://ibn.fm/7LTxY). And SPYR could benefit from this increased interest should it go ahead with its plan. The company has also set its sights on acquisition targets to add new product lines as well as intellectual property (“IP”) to its current portfolio (https://ibn.fm/yWGud). “I’m always looking for new and innovative technologies, and as a result, have come across several potentially awesome IP targets that may be worth acquiring,” said Zink. “Some of these are AI-based and would complement and expand some of our existing product lines really well. Others represent some significantly innovative technologies that could be at the core of new product lines.” On his part, SPYR Technologies CEO Tim Matula expressed his appreciation for the work Zink and Applied Magix are doing, further noting that the acquisitions, while complementary, could potentially bring new revenue streams. It is noteworthy that each of the products and plans that form part of the forward-looking expansion strategy is merely a consideration and is currently speculative. Nonetheless, the company expects to update the general public as soon as the considerations morph into actualized developments. For product information, please see the Applied Magix website at https://AppliedMagix.com, or specific product sites:

• MagixDrive Wireless CarPlay Adapter – https://appliedmagix.com/MagixDriveBundle
• HomeKit Secure Video Camera with iCloud Storage – https://appliedmagix.com/HomeKitCamera
• Multipurpose Sensor with Alarm – https://appliedmagix.com/HomeKitAlarmSensor
• Environment and Motion Sensor – https://appliedmagix.com/HomeKitMotionSensor
• Window and Door Contact Sensor – https://appliedmagix.com/HomeKitContactSensor
• MagixBlock USB DataBlocker – https://appliedmagix.com/MagixBlock
• MagixCharge Dual USB-C Car Charger – https://appliedmagix.com/MagixCharge

For more information, visit the company’s website at www.Spyr.com. NOTE TO INVESTORS: The latest news and updates relating to SPYR are available in the company’s newsroom at https://ibn.fm/SPYR

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW) 8033 Sunset Blvd Suite 1037-IW Los Angeles, CA 90046 310.299.1717 Office www.InvestorWire.com Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork.

• Aditxt is commercializing new innovations with focus on mapping and reprogramming the immune system
• Aditxt is actively adding distribution channel partners for AditxtScore(TM) throughout the U.S. and globally
• The company aims to expand reimbursement coverage for AditxtScore(TM) for COVID-19 from private insurance and public payers while developing and commercializing tests for other indications
• Aditxt intends to advance its ADi(TM) therapeutics pipeline into clinical trials in the coming months, with initial studies targeting psoriasis, type 1 diabetes, and skin allograft transplantation
• The company is led by a team of experts coming from a variety of different scientific fields and business backgrounds

Aditxt (NASDAQ: ADTX) is a biotech innovation company developing technologies focused on mapping and reprogramming the immune system. Aditxt’s immune mapping technologies are designed to provide a personalized immune profile. Aditxt’s immune reprogramming technologies, currently preclinical, are being developed to retrain the immune system to induce tolerance to address rejection of transplanted organs, autoimmune diseases, and allergies. As further discussed below, the company’s first commercial product is an immune mapping technology, AditxtScore(TM), which is designed to provide a personalized profile of the immune system. The company’s preclinical immune reprogramming technology, Apoptotic DNA Immunotherapy(TM) (“ADi(TM)”), aims to retrain the immune system to induce tolerance, with the goal of addressing vast unmet needs in transplanted organ rejection, autoimmune diseases, and allergies. The company is developing specific ADi(TM) products for psoriasis, type 1 diabetes, and skin grafting. Headquartered in Richmond, Virginia, Aditxt also operates locations in Silicon Valley and New York. AditxtScore(TM) AditxtScore(TM) is a proprietary platform designed to provide a personalized, comprehensive profile of an individual’s immune system. The underlying technology, licensed from Stanford University through an exclusive worldwide agreement, offers a highly sensitive and accurate method of detecting and quantifying cellular responses, allowing greater specificity, quantification, and amplification of both clinical and commercial opportunities. The company’s first commercial application of the platform, AditxtScore(TM) for COVID-19, delivers timely reports on vulnerability and immune status relating to SARS-CoV-2 and its known variants, giving consumers and physicians the data needed to make informed health decisions. Potential future applications will offer early detection of an array of conditions, including diabetes, cardio-metabolic maladies and hormonal imbalances. Aditxt’s AditxtScore(TM) immune monitoring center in Richmond, Virginia, is operational and designed to support the anticipated increased demand for AditxtScore(TM) as well as related products and services. The company is currently scaling its capabilities at this location, with a goal of processing up to 10 million immune system tests/reports annually. ADi(TM) ADi(TM) is Aditxt’s immune reprogramming platform addressing disease-causing immune responses while maintaining the immune system’s ability to combat pathogenic infection. The company is commercializing a nucleic acid-based technology called Apoptotic DNA Immunotherapy(TM) (ADi(TM)) which utilizes a novel approach that mimics the way our bodies naturally induce tolerance to our own tissues (therapeutically induced immune tolerance). Aditxt believes its ADi(TM) technology platform can be engineered to address a wide variety of indications. Aditxt is currently developing ADi(TM) products for psoriasis, type 1 diabetes and skin grafting. Currently, immuno-tolerance is achievable through chimerism and cell-based therapy, but there is a clinical need for a more practical and cost-effective approach which:

• Can be made into a product
• Does not require additional hospitalization
• Is simple to produce and ship

Preclinical studies have demonstrated that ADi(TM) treatment significantly and substantially prolongs graft survival, in addition to successfully “reversing” other established immune-mediated inflammatory processes. ADi(TM) treatment is not expected to require hospitalization, instead being delivered as an injection in minute amounts into the skin. IP Portfolio Both AditxtScore(TM) and ADi(TM) are supported by a strong IP portfolio. AditxtScore(TM), built upon initial technology invented, licensed from and used at Stanford University, is protected by U.S. patents encompassing methods, systems, and kits for detection and measurement of specific immune responses. ADi(TM) technology is protected by seven patent families, including:

• 8 U.S. patents
• 4 pending U.S. patent applications
• 86 foreign patents and 14 pending foreign patent applications spanning the EU, Australia, Canada, Japan, China, India and Hong Kong

These patents are broadly categorized into three groups:

• Autoimmune diseases and Type 1 Diabetes
• Organ transplantation and a method of producing plasmid DNA to prevent immune activation
• Composition of matter for a tolerance delivery system for antigens of interest

Aditxt also possesses and/or in-licenses substantial know-how and trade secrets relating to the development and commercialization of its product candidates, including related manufacturing processes and technologies. Market Overview The potential market opportunities presented by immune monitoring and reprogramming are extensive, particularly as Aditxt continues to evaluate additional applications for the platforms. The company’s initial focus on organ transplantation and related autoimmune response provides some insight into the potential of its approach. According to BCC Research, the global organ and tissue transplantation and alternatives market is on course to reach $120.3 billion by 2024, recording a CAGR of 7.4% from 2019. Industry data suggest that approximately 50% of all transplanted organs are rejected within 10-12 years, further highlighting the critical need for a practical, cost-effective solution to harmful autoimmune responses. Through its focus on the COVID-19 testing market with AditxtScore(TM), Aditxt demonstrated the wide-ranging potential of its portfolio. Fortune Business Insights estimated the global COVID-19 diagnostics market at $48.64 billion for 2022. While demand for COVID-19 diagnostics is expected to lessen in the coming years, Aditxt will be uniquely positioned to leverage its existing infrastructure stemming from these operations as the company works to advance broader applications for the AditxtScore(TM) platform. Leadership Team Amro Albanna is the Co-Founder, Chairman, and CEO of Aditxt. He has founded multiple startups to commercialize innovations in various industries, including healthcare, enterprise software, telecommunications, nano technology, consumer health, and biotech. Mr. Albanna has led numerous M&A and going-public transactions as a founder, co-founder, and senior executive. Shahrokh Shabahang, D.D.S., MS, Ph.D., is the company’s Co-Founder, Chief Innovation Officer, and a member of its board. He brings to the team more than 20 years of experience in developing and commercializing life science technologies focused on product and clinical development in the fields of microbiology and immunology. Corinne Pankovcin, CPA, MBA, is the President of Aditxt. Prior to joining Aditxt, Ms. Pankovcin served as CFO for several world class organizations, including Business Development Corporation of America, Blackrock Kelso Capital and AIG Capital Partners. In these roles, Ms. Pankovcin was responsible for executing portfolio investments and managing significant M&A transactions. Thomas Farley is the Chief Financial Officer of Aditxt. From December 2015 to June 2020, Mr. Farley was the Controller and Treasurer of Business Development Corporation of America (“BDCA”), a publicly listed business development company. Prior thereto, from January 2011 to August 2015, Mr. Farley was the Senior Controller of Blackrock Capital Investment Corporation (NASDAQ: BKCC). Prior to joining BlackRock Capital Investment Corporation, Mr. Farley was a Senior Controller for PineBridge Investments Emerging Markets practice. Mr. Farley was also an Accounting Manager for Bessemer Venture Partners prior to his tenue at PineBridge. Mr. Farley began his career with PricewaterhouseCoopers LLP, from 1996 to 2001. Mr. Farley earned his B.S. in Accounting from Long Island University and is a Certified Public Accountant. Rowena Albanna is the company’s Chief Operating Officer. Ms. Albanna has over two decades of experience in senior leadership roles for both technology startups and public companies. Ms. Albanna’s experience spans a wide variety of industries, including biotechnology, insect control, nanotechnology, consumer electronics, financials, telecommunications, e-commerce, online marketing, medical, and defense. Matthew Shatzkes is the Chief Legal Officer and General Counsel of Aditxt. As a former partner at an AM Law 50 law firm, Mr. Shatzkes advised a wide variety of healthcare related entities, including biotech companies, on corporate, regulatory, and strategic business matters. Mr. Shatzkes will oversee all aspects of the legal functions at Aditxt, including, providing advice and counsel on governance, regulatory matters, strategic alliances, mergers and acquisitions, and commercial transactions. For more information, visit the company’s website at www.Aditxt.com. NOTE TO INVESTORS: The latest news and updates relating to ADTX are available in the company’s newsroom at https://ibn.fm/ADTX

• A company’s ability to establish, maintain strong brand equity creates passionate, loyal consumers
• Creating a community, differentiating are essential steps in building a powerful brand
• Since inception, SHRG has devoted itself to creating a community where entrepreneurs and consumers alike can find health, wealth and happiness

Creating a recognizable brand is essential to success for companies in any industry, especially in direct sales. Direct Selling News (“DSN”) recently shared key tips to “up your brand game” (https://ibn.fm/oQLYO), and many smart companies in the space, such as Sharing Services Global (OTCQB: SHRG), understand that “creating and maintaining strong brand equity creates consumers that are passionate. And once a consumer becomes passionate about a brand, they assign added value to it.” In what it calls a “Brand Equity Playbook,” DSN explores the value of creating a community and differentiating. In regards to creating a community, the article observes that “conventional wisdom surrounding brand building almost always lists ‘know your customer’ as the most important thing. “But knowing who your customer is isn’t nearly enough,” the article continues. “You also need to understand your customer; connect with your customer; and—most importantly—create shared experiences with your customer. It’s imperative to develop a fuller understanding of not just who they are but who they want to be; why they are interested in your products (or your opportunity); what needs your products can fulfill; and what they hope to accomplish from their interaction with you.” In addition, the article notes that “one of the most crucial steps to building brand equity is to differentiate yourself from the competition. This is especially true for direct sellers. In this channel, you aren’t just marketing products. You are offering a community, an opportunity and a partnership. Be clear—in tangible, compelling terms—what the products can do for your customers and why that matters.” Sharing Services could be the poster child for these brand-building tips. Since inception, the company has devoted itself to creating a community where both entrepreneurs and consumers can find health, wealth and happiness (https://ibn.fm/LgFJ9). The company has created a place where entrepreneurs can succeed as they work together to serve others in a community where technology is a strength, research is the foundation to excellence in decision making and quality is fundamental to sustainable success. The company further differentiates itself by replacing complexity with simplicity and making timely decisions. “The best brands live permanently in our imagination,” the DSN article concludes. “We have happy memories and positive experiences we associate with them. Their products help us live better, simpler, smarter or healthier lives. The value they bring us keeps us consistently engaged, entertained and excited.” SHRG has done a stellar job of incorporating these simple principles in its growing business as it focuses on partnering with business builders and customers alike to build a powerful brand that offers the potential to change people’s lives. Sharing Services Global Corporation is a publicly traded diversified company dedicated to maximizing shareholder value through the acquisition and development of innovative companies, products and technologies. The Sharing Services combined platform leverages the capabilities and expertise of various companies that market and sell products direct to the consumer. Its primary division includes Elevacity U.S. LLC, the parent company of the Happy Co. and a sales and marketing company based on utilization of independent contractors as the sales force. For more information, visit the company’s websites at www.SHRGInc.com, www.TheHappyCo.com, and www.ShareHapiTravel.com. NOTE TO INVESTORS: The latest news and updates relating to SHRG are available in the company’s newsroom at http://ibn.fm/SHRG